|
1
|
Huang YW, Kuo CT, Stoner K, Huang TH and
Wang LS: An overview of epigenetics and chemoprevention. FEBS Lett.
585:2129–2136. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamm CA, Xie H, Costa FF, Vanin EF, Seftor
EA, Sredni ST, Bischof J, Wang D, Bonaldo MF, Hendrix MJ and Soares
MB: Global demethylation of rat chondrosarcoma cells after
treatment with 5-aza-2′-deoxycytidine results in increased
tumorigenicity. PLoS One. 4:e83402009.PubMed/NCBI
|
|
3
|
Roman-Gomez J, Jimenez-Velasco A, Agirre
X, Cervantes F, Sanchez J, Garate L, Barrios M, Castillejo JA,
Navarro G, Colomer D, Prosper F, Heiniger A and Torres A: Promoter
hypomethylation of the LINE-1 retrotransposable elements activates
sense/antisense transcription and marks the progression of chronic
myeloid leukemia. Oncogene. 24:7213–7223. 2005. View Article : Google Scholar
|
|
4
|
Wu SC and Zhang Y: Active DNA
demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol.
11:607–620. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morgan HD, Santos F, Green K, Dean W and
Reik W: Epigenetic reprogramming in mammals. Hum Mol Genet.
14:R47–R58. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dean W, Santos F, Stojkovic M,
Zakhartchenko V, Walter J, Wolf E and Reik W: Conservation of
methylation reprogramming in mammalian development: aberrant
reprogramming in cloned embryos. Proc Natl Acad Sci USA.
98:13734–13738. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bian Y, Alberio R, Allegrucci C, Campbell
KH and Johnson AD: Epigenetic marks in somatic chromatin are
remodelled to resemble pluripotent nuclei by amphibian oocyte
extracts. Epigenetics. 4:194–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miyamoto K, Tsukiyama T, Yang Y, Li N,
Minami N, Yamada M and Imai H: Cell-free extracts from mammalian
oocytes partially induce nuclear reprogramming in somatic cells.
Biol Reprod. 80:935–943. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ostrup O, Hyttel P, Klaerke DA and Collas
P: Remodeling of ribosomal genes in somatic cells by Xenopus
egg extract. Biochem Biophys Res Commun. 412:487–493. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oliveri RS, Kalisz M, Schjerling CK,
Andersen CY, Borup R and Byskov AG: Evaluation in mammalian oocytes
of gene transcripts linked to epigenetic reprogramming.
Reproduction. 134:549–558. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morgan HD, Dean W, Coker HA, Reik W and
Petersen-Mahrt SK: Activation-induced cytidine deaminase deaminates
5-methylcytosine in DNA and is expressed in pluripotent tissues:
implications for epigenetic reprogramming. J Biol Chem.
279:52353–52360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iqbal K, Jin SG, Pfeifer GP and Szabó PE:
Reprogramming of the paternal genome upon fertilization involves
genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci USA.
108:3642–3647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Daskalos A, Nikolaidis G, Xinarianos G,
Savvari P, Cassidy A, Zakopoulou R, Kotsinas A, Gorgoulis V, Field
JK and Liloglou T: Hypomethylation of retrotransposable elements
correlates with genomic instability in non-small cell lung cancer.
Int J Cancer. 124:81–87. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li QL, Kim HR, Kim WJ, Choi JK, Lee YH,
Kim HM, Li LS, Kim H, Chang J, Ito Y, Youl Lee K and Bae SC:
Transcriptional silencing of the RUNX3 gene by CpG hypermethylation
is associated with lung cancer. Biochem Biophys Res Commun.
314:223–228. 2004. View Article : Google Scholar
|
|
15
|
Reinhold WC, Reimers MA, Lorenzi P, Ho J,
Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O,
Pommier YG and Weinstein JN: Multifactorial regulation of
E-cadherin expression: an integrative study. Mol Cancer Ther.
9:1–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Endoh H, Yatabe Y, Shimizu S, Tajima K,
Kuwano H, Takahashi T and Mitsudomi T: RASSF1A gene inactivation in
non-small cell lung cancer and its clinical implication. Int J
Cancer. 106:45–51. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mazieres J, He B, You L, Xu Z, Lee AY,
Mikami I, Reguart N, Rosell R, McCormick F and Jablons DM: Wnt
inhibitory factor-1 is silenced by promoter hypermethylation in
human lung cancer. Cancer Res. 64:4717–4720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takezawa K, Okamoto I, Yonesaka K,
Hatashita E, Yamada Y, Fukuoka M and Nakagawa K: Sorafenib inhibits
non-small cell lung cancer cell growth by targeting B-RAF in KRAS
wild-type cells and C-RAF in KRAS mutant cells. Cancer Res.
69:6515–6521. 2009. View Article : Google Scholar : PubMed/NCBI
|
